Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia

[11] Faugere M(2019)Gender differences in correlates of cognition in first-episode psychosis Psychiatry Res 271 412-154

[12] Boyer L(2015)Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects Eur Psychiatry 30 242-9

[13] Fond G(2014)No sex differences in neuropsychological performance in first episode psychosis patients Prog Neuropsychopharmacol Biol Psychiatry 48 149-43

[14] Richieri R(2020)Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia Transl Psychiatry 10 18-202

[15] Faget C(2015)Gender differences in cognitive deficits in schizophrenia with and without diabetes Compr Psychiatry 63 1-1510

[16] Cermolacce M(2019)Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia J Psychiatr Res 112 38-112

[17] Philip P(2016)Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population Psychiatry Res 238 196-242

[18] Vion-Dury J(2020)Interrelationships between BDNF, superoxide dismutase, and cognitive impairment in drug-naive first-episode patients with schizophrenia Schizophr Bull. 46 1498-1261

[19] Lancon C(2020)High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophrenia Transl Psychiatry 10 79-1189

[20] Li X(2020)P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery Schizophr Res 215 105-115

[11] Faugere M(2019)Gender differences in correlates of cognition in first-episode psychosis Psychiatry Res 271 412-154

[12] Boyer L(2015)Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects Eur Psychiatry 30 242-9

[13] Fond G(2014)No sex differences in neuropsychological performance in first episode psychosis patients Prog Neuropsychopharmacol Biol Psychiatry 48 149-43

[14] Richieri R(2020)Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia Transl Psychiatry 10 18-202

[15] Faget C(2015)Gender differences in cognitive deficits in schizophrenia with and without diabetes Compr Psychiatry 63 1-1510

[16] Cermolacce M(2019)Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia J Psychiatr Res 112 38-112

[17] Philip P(2016)Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population Psychiatry Res 238 196-242

[18] Vion-Dury J(2020)Interrelationships between BDNF, superoxide dismutase, and cognitive impairment in drug-naive first-episode patients with schizophrenia Schizophr Bull. 46 1498-1261

[19] Lancon C(2020)High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophrenia Transl Psychiatry 10 79-1189

[20] Li X(2020)P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery Schizophr Res 215 105-115